Cargando…

Application of serum Golgi protein-73 in the management of chronic liver disease

Detalles Bibliográficos
Autores principales:	Yao, Ming-Jie, Wang, Lei-Jie, Liu, Shuang, Lu, Feng-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Medical Progress
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104241/ https://www.ncbi.nlm.nih.gov/pubmed/33323825 http://dx.doi.org/10.1097/CM9.0000000000001296

Ejemplares similares

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer
por: Xu, Zheng-Ju, et al.
Publicado: (2022)

Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B
por: XU, ZHENGJU, et al.
Publicado: (2015)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
por: Yang, Danli, et al.
Publicado: (2021)

Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease
por: Liu, Langli, et al.
Publicado: (2018)

Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma
por: Liu, Tianhui, et al.
Publicado: (2017)

Diagnostic Value of Serum Golgi Protein 73 for Liver Inflammation in Patients with Autoimmune Hepatitis and Primary Biliary Cholangitis
por: Yao, Mingjie, et al.
Publicado: (2022)

Use of serum Golgi protein 73 for screening chronic hepatitis B virus infection patients needing antiviral therapy in the community
por: Duan, Jinwei, et al.
Publicado: (2022)

Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries
por: Qian, Xiangjun, et al.
Publicado: (2019)

Home-based spirometry in the self-management of chronic obstructive pulmonary disease
por: Zhang, Teng-Yue, et al.
Publicado: (2021)

Golgi protein 73 and its diagnostic value in liver diseases
por: Xia, Yanyan, et al.
Publicado: (2018)

Progress in the mechanism of radiation-induced lung injury
por: Ying, Hang-Jie, et al.
Publicado: (2021)

Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis
por: Wang, Leijie, et al.
Publicado: (2020)

Golgi Protein 73 (GP73) Serum Levels Predict Outcome after Resection of Biliary Tract Cancer
por: Loosen, Sven H., et al.
Publicado: (2022)

Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy
por: Luo, Wen-Xin, et al.
Publicado: (2021)

Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF
por: Tong, Jingjing, et al.
Publicado: (2022)

Serum Cartilage Oligomeric Matrix Protein and Golgi Protein-73: New Diagnostic and Predictive Tools for Liver Fibrosis and Hepatocellular Cancer?
por: Gatselis, Nikolaos K., et al.
Publicado: (2021)

Potential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis
por: Zhang, Run-Feng, et al.
Publicado: (2021)

Imaging-based deep learning in liver diseases
por: Yuan, Enyu, et al.
Publicado: (2022)

Autophagy in intestinal injury caused by severe acute pancreatitis
por: Li, Hong-Yao, et al.
Publicado: (2021)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
por: Yu, Wei-Ming, et al.
Publicado: (2023)

The Predictive Value of Golgi Protein 73 in Differentiating Benign from Malignant Liver Tumors
por: Bröker, Mirelle E. E., et al.
Publicado: (2014)

Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients
por: Gatselis, Nikolaos K, et al.
Publicado: (2020)

Progress of pyroptosis in acute pancreatitis
por: Li, Hong-Yao, et al.
Publicado: (2021)

Current application of immunotherapy in melanoma
por: Xie, Ruxin, et al.
Publicado: (2023)

Radiation therapy for patients with brain metastases from non-small cell lung cancer without driven gene mutation
por: Li, Pei-Jie, et al.
Publicado: (2020)

Intracerebral hemorrhage and small vessel disease
por: Li, Qi, et al.
Publicado: (2021)

Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis
por: YANG, JING, et al.
Publicado: (2015)

HIV-associated dyslipidemia: pathogenesis and its management
por: Wan, Zhikai, et al.
Publicado: (2023)

The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis
por: Zhao, Shoujie, et al.
Publicado: (2020)

Golgi protein 73, hepatocellular carcinoma and other types of cancers
por: Wang, Yanan, et al.
Publicado: (2020)

Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma
por: Hu, Xinyang, et al.
Publicado: (2023)

Co-mutations in tumor immune microenvironment and immunotherapy
por: Ma, Ling, et al.
Publicado: (2021)

Artificial intelligence-powered remote monitoring of patients with chronic obstructive pulmonary disease
por: Li, Xuying, et al.
Publicado: (2021)

Advances in the modification of injectable calcium-phosphate-based bone cements for clinical application
por: Wang, Xiao-Hui, et al.
Publicado: (2020)

Lysosomal-associated protein transmembrane-4 beta: a novel potential biomarker for cancer therapy with multiple functions
por: Xu, Xi-Chao, et al.
Publicado: (2021)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis
por: Dai, Meiyu, et al.
Publicado: (2015)

Nélaton, 1807–73
Publicado: (1873)

Caroli disease: an update on pathogenesis
por: Shi, Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mfh6o5hd71fgcjp9pr7j43g6vo